Allergy Therapeutics plc (AGYTF)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 59.58 Million | 72.76 Million | 84.33 Million | 78.2 Million | 73.71 Million | 68.34 Million |
| Cost of Revenue | 26.34 Million | 23.26 Million | 22.1 Million | 20.2 Million | 18.37 Million | 17.01 Million |
| Gross Profit | 33.24 Million | 49.5 Million | 62.22 Million | 58 Million | 55.33 Million | 51.33 Million |
| Operating Expenses | 72.89 Million | 61.75 Million | 58.19 Million | 49.69 Million | 50.94 Million | 58.06 Million |
| Selling, General and Administrative Expenses | 48.88 Million | 46.83 Million | 45.87 Million | 44.48 Million | 44.59 Million | 42.67 Million |
| Research and Development Expenses | 20.12 Million | 15.65 Million | 12.88 Million | 5.84 Million | 6.95 Million | 16.01 Million |
| Other Expenses | 3.89 Million | - | - | - | - | - |
| Cost and Expenses | 99.24 Million | 85.01 Million | 80.3 Million | 69.89 Million | 69.32 Million | 75.07 Million |
| Operating Income | -39.65 Million | -12.24 Million | 4.03 Million | 8.3 Million | 4.39 Million | -6.73 Million |
| Interest Expense | 2.44 Million | 669 Thousand | 491 Thousand | 504 Thousand | 201 Thousand | 320 Thousand |
| Income Tax Expense | 1.3 Million | 1.11 Million | 771 Thousand | 1.01 Million | 826 Thousand | 637 Thousand |
| Earnings before Tax | -41.76 Million | -12.65 Million | 3.65 Million | 8.07 Million | 4.29 Million | -6.89 Million |
| Net Income | -43.07 Million | -13.77 Million | 2.88 Million | 7.05 Million | 3.46 Million | -7.53 Million |
| Earnings Per Share Basic | -0.06 | -0.01 | 0.00 | 0.01 | 0.00 | -0.01 |
| Earnings Per Share Diluted | -0.06 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Weighted Average Shares Outstanding | 669.84 Million | 1.39 Billion | 1.38 Billion | 1.38 Billion | 1.37 Billion | 595.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 670.35 Million | 1.39 Billion | 1.46 Billion | 1.46 Billion | 1.45 Billion | 595.09 Million |
| Gross Margin | 0.56 | 0.68 | 0.74 | 0.74 | 0.75 | 0.75 |
| EBIT Margin | -0.59 | -0.11 | 0.10 | 0.16 | 0.09 | -0.07 |
| Profit Margin | -0.72 | -0.19 | 0.03 | 0.09 | 0.05 | -0.11 |
| EBITDA | -35.1 Million | -7.82 Million | 8.28 Million | 12.48 Million | 6.58 Million | -4.55 Million |
| Earnings Before Tax Margin | -0.67 | -0.17 | 0.05 | 0.11 | 0.06 | -0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 16.78 Million | 16.78 Million | 19.68 Million | 60.95 Million | 9.84 Million | 39.9 Million |
| Cost of Revenue | 6.52 Million | 6.52 Million | 12.22 Million | 26.34 Million | 6.11 Million | 14.11 Million |
| Gross Profit | 10.26 Million | 10.26 Million | 7.46 Million | 34.61 Million | 3.73 Million | 25.78 Million |
| Operating Expenses | 16.2 Million | 16.2 Million | 35.4 Million | 68.05 Million | 19.72 Million | 33.59 Million |
| Selling, General and Administrative Expenses | 10.68 Million | 10.68 Million | 23.78 Million | - | 12.03 Million | 25.1 Million |
| Research and Development Expenses | 5.69 Million | 5.69 Million | 11.62 Million | - | 5.81 Million | 8.49 Million |
| Other Expenses | -170 Thousand | - | - | - | - | - |
| Cost and Expenses | 22.72 Million | 22.72 Million | 47.63 Million | 94.4 Million | 25.83 Million | 47.71 Million |
| Operating Income | -5.94 Million | -5.73 Million | -27.94 Million | -36.12 Million | -13.82 Million | -7.81 Million |
| Interest Expense | 3.18 Million | - | 2.04 Million | 2.74 Million | - | 398 Thousand |
| Income Tax Expense | 367.5 Thousand | 367.5 Thousand | 999 Thousand | 1.19 Million | 499.5 Thousand | 306 Thousand |
| Earnings before Tax | -7.45 Million | -7.45 Million | -33.56 Million | -49.82 Million | -16.78 Million | -8.19 Million |
| Net Income | -7.82 Million | -7.82 Million | -34.56 Million | -51.02 Million | -17.28 Million | -8.5 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.02 | - | -0.03 | -0.01 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.02 | - | -0.03 | -0.01 |
| Weighted Average Shares Outstanding | 2.69 Billion | 2.69 Billion | 1.47 Billion | 1.45 Billion | 679.04 Million | 1.43 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.72 Billion | 2.72 Billion | 1.47 Billion | 1.45 Billion | 679.1 Million | 1.43 Billion |
| Gross Margin | 0.61 | 0.61 | 0.38 | 0.57 | 0.38 | 0.65 |
| EBIT Margin | -0.28 | -0.28 | -1.31 | - | -1.40 | -0.14 |
| Profit Margin | -0.47 | -0.47 | -1.76 | -0.84 | -1.76 | -0.21 |
| EBITDA | -4.67 Million | -4.67 Million | -25.82 Million | - | -13.82 Million | -5.71 Million |
| Earnings Before Tax Margin | -0.35 | -0.34 | -1.42 | -0.59 | -1.40 | -0.20 |
CLN
ENTRINT
JETAIRWAYS
2388
DGE
GUER